No Data
No Data
Private Companies Are Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Biggest Owners and Were Hit After Market Cap Dropped CN¥581m
Key Insights Qingdao Haier BiomedicalLtd's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 4 investors have a
Qingdao Haier Biomedical Co., Ltd. (688139.SH): Qijun Investment has completed the shareholding of 1.6% of the company's shares.
Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that as of the date of the announcement, its shareholder Ningbo Meishan Bonded Port Area Qijun Equity Investment Partnership (Limited Partnership) has...
Qingdao Haier Biomedical Co., Ltd. (688139.SH): did not repurchase shares in June.
On June 2024, Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that the company did not repurchase shares through the Shanghai Stock Exchange trading system through centralized bidding trading method. As of June 30, 2024, the company has repurchased 815,617 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding trading method, accounting for 0.26% of the total share capital of 317,952,508 shares, with the highest repurchase price of 32.31 yuan/share and the lowest price of 27.40 yuan/share. The total amount of funds paid was RMB 25,654,978.4.
Investors Interested In Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Earnings
With a median price-to-earnings (or "P/E") ratio of close to 30x in China, you could be forgiven for feeling indifferent about Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) P/E ratio of 30.7x. Ho
Shareholder Qi Jun Investment of Qingdao Haier Biomedical Co., Ltd. (688139.SH) has cumulatively reduced its shareholding in the company by 1.29%.
Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that on June 11, 2024, the company received a shareholder's notice from Ningbo...
Qingdao Haier Biomedical Co., Ltd. (688139.SH) did not repurchase its shares in May.
On May 2024, Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that the company did not repurchase shares through the Shanghai Stock Exchange trading system by centralized bidding trading. As of May 31, 2024, the company has accumulated repurchased 815,617 shares through the Shanghai Stock Exchange trading system, accounting for 0.26% of the company's total equity of 317,952,508 shares, with a highest repurchased price of 32.31 yuan/share and a lowest repurchased price of 27.40 yuan/share. The total amount paid was RMB 25,654,978.4.
No Data